Lifecore Biomedical Inc (LFCR)
5.06
-0.14
(-2.69%)
USD |
NASDAQ |
Jun 17, 11:04
Lifecore Biomedical Cash from Operations (Quarterly): -17.29M for May 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2023 | -0.272M |
| February 28, 2023 | -12.69M |
| November 30, 2022 | -2.948M |
| August 31, 2022 | -1.533M |
| May 31, 2022 | -0.548M |
| February 28, 2022 | -17.74M |
| November 30, 2021 | -5.137M |
| August 31, 2021 | 0.831M |
| May 31, 2021 | 5.871M |
| February 28, 2021 | -7.856M |
| November 30, 2020 | 1.435M |
| August 31, 2020 | 17.02M |
| May 31, 2020 | -12.70M |
| February 29, 2020 | 10.58M |
| November 30, 2019 | -9.483M |
| August 31, 2019 | -5.439M |
| May 31, 2019 | -1.429M |
| February 28, 2019 | 12.65M |
| November 30, 2018 | 2.617M |
| August 31, 2018 | 2.186M |
| May 31, 2018 | -0.521M |
| February 28, 2018 | 13.96M |
| November 30, 2017 | 2.886M |
| August 31, 2017 | 3.45M |
| May 31, 2017 | 6.657M |
| Date | Value |
|---|---|
| February 28, 2017 | 17.65M |
| November 30, 2016 | -0.94M |
| August 31, 2016 | 6.467M |
| May 31, 2016 | 14.33M |
| February 29, 2016 | 4.148M |
| November 30, 2015 | 4.047M |
| August 31, 2015 | -1.765M |
| May 31, 2015 | 13.24M |
| February 28, 2015 | 10.03M |
| November 30, 2014 | -0.593M |
| August 31, 2014 | 3.943M |
| May 31, 2014 | 7.211M |
| February 28, 2014 | 9.541M |
| November 30, 2013 | -0.245M |
| August 31, 2013 | 4.538M |
| May 31, 2013 | 7.755M |
| February 28, 2013 | 11.09M |
| November 30, 2012 | -2.701M |
| August 31, 2012 | 5.085M |
| May 31, 2012 | 13.65M |
| February 29, 2012 | 9.277M |
| November 30, 2011 | -5.10M |
| August 31, 2011 | 4.358M |
| May 31, 2011 | 2.035M |
| February 28, 2011 | 10.37M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-17.74M
Minimum
Feb 2022
17.02M
Maximum
Aug 2020
-2.538M
Average
-2.240M
Median
Cash from Operations (Quarterly) Benchmarks
| Aquestive Therapeutics Inc | -10.38M |
| SELLAS Life Sciences Group Inc | -10.76M |
| ADMA Biologics Inc | -2.218M |
| Relmada Therapeutics Inc | -13.04M |
| Jaguar Health Inc | -7.047M |